Glazer Capital, LLC 13D/13G Filings for Harpoon Therapeutics, Inc. (HARP)

Glazer Capital, LLC 13D and 13G filings for Harpoon Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-03-18
5:35 pm
Unchanged
2024-03-0813GHarpoon Therapeutics, Inc.
HARP
Glazer Capital, LLC0
0.000%
0
(Unchanged)
Filing